共 36 条
Synthesis and inhibition of cancer cell proliferation of (1,3′)-bis-tetrahydroisoquinolines and piperazine systems
被引:17
作者:
Aubry, Sylvain
Pellet-Rostaing, Stephane
Chabert, Jeremie Fournier dit
Ducki, Sylvie
Lemaire, Marc
机构:
[1] Inst Chim & Biochem Mol & Supramol, Lab Catalyse & Synthese Organ, F-69622 Villeurbanne, France
[2] CNRS, UMR5246, F-69622 Villeurbanne, France
[3] Univ Lyon 1, F-69622 Villeurbanne, France
[4] Inst Natl Sci Appl, F-69622 Villeurbanne, France
[5] CPE Lyon, F-69616 Villeurbanne, France
[6] Univ Salford, Ctr Mol Drug Design, Salford M5 4WT, Lancs, England
基金:
英国生物技术与生命科学研究理事会;
关键词:
piperazine systems;
synthesis;
cancer cell proliferation;
F-flow cytometry;
D O I:
10.1016/j.bmcl.2007.01.108
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Some (1,3')-bis-tetrahydroisoquinolines were reported as scaffold intermediates for the synthesis of pentacyclic piperazine core alkaloids and their cytotoxicity against cancerous cell lines was evaluated. The NMR and X-ray structural assignments revealed an anti C3-C11 backbone stereochemistry of piperazine structures. Inhibition of cancer cell proliferation of (1,3')-bis-tetrahydroisoquinoline scaffolds and pentacyclic piperazine systems was assessed against three human cancer cell lines (K562 myelogenous leukemia, A549 lung carcinoma, MCF-7 breast adenocarcinoma) and both mouse tumor cell lines of blood (P388) and lymphocytic (L1210) leukemia with considerable activity against the latter. The cell cycle analysis was also studied by flow cytometry measurement on K562 cell line. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2598 / 2602
页数:5
相关论文